A Multicenter, Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study Evaluating the Initial Efficacy, Safety, and Tolerability of LW402 Tablets in Patients with Moderate and Severe Active Rheumatoid Arthritis
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs LW 402 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Longwood Biopharma
- 04 Feb 2025 New trial record